(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate activities at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10 at 11:00 a.m. Pacific Time. The presentation will be held in the Elizabethan Room A/B at The Westin St. Francis Hotel in San Francisco. A Q&A breakout session with Dr. Lynch and Larry Bullock, the Company’s CFO, is scheduled for 11:30 in the Sussex Room.
